DOAC ADRs Retrospective Study

Stopped early

Conditions studied: Drug-Related Side Effects and Adverse Reactions

In brief

This retrospective study's objective is to evaluate if Cipherome's algorithm could have predicted the serious adverse drug reactions (ADRs) experienced by patients while on direct oral anti-coagulants (DOACs).

Key facts

Study ID

NCT04247919

Run by

Cipherome, Inc.

People needed

3

Starts

2020-01-10

Expected to finish

2020-07-24

Last updated by the study team

2021-03-08

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Any adult patient 18 years and older, who experienced a serious adverse drug reaction while taking a DOAC and is able to provide informed consent.

You may not qualify if…

• Failure to provide informed consent

Where it is running

• Santa Clara Valley Medical Center — San Jose, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.